Nuvalent
Jay Dietz is an experienced talent acquisition leader with extensive expertise in the biopharma sector. Currently serving as the Head of Talent Acquisition at Nuvalent, Inc. and Talent Resources, Jay Dietz has a proven track record of full life cycle recruiting and implementing comprehensive talent acquisition strategies. Previous roles include senior positions at Cedilla Therapeutics, Arbor Biotechnologies, and PharmaEssentia U.S.A. Corporation, where Jay Dietz was instrumental in building talent acquisition functions and managing recruitment processes for key operational areas. With a foundation in R&D and regulatory affairs, Jay Dietz has also held director and associate director roles at notable organizations such as Ipsen, TESARO, Cubist Pharmaceuticals/Merck, and Biogen Idec. Jay Dietz's diverse skill set is supported by a solid educational background from Southern New Hampshire University and earlier schooling at Chapel Hill - Chauncy Hall and Framingham South High School.
This person is not in any teams
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.